| __timestamp | Sanofi | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 21769000000 | 580006000 |
| Thursday, January 1, 2015 | 23942000000 | 676585000 |
| Friday, January 1, 2016 | 23995000000 | 778966000 |
| Sunday, January 1, 2017 | 24774000000 | 671251000 |
| Monday, January 1, 2018 | 24356000000 | 463508000 |
| Tuesday, January 1, 2019 | 25655000000 | 445724000 |
| Wednesday, January 1, 2020 | 25212000000 | 399725000 |
| Friday, January 1, 2021 | 26920000000 | 296656000 |
| Saturday, January 1, 2022 | 31697000000 | 293122000 |
| Sunday, January 1, 2023 | 31797000000 | 268323000 |
| Monday, January 1, 2024 | 304979000 |
Data in motion
In the ever-evolving pharmaceutical industry, the financial health of companies is a key indicator of their market position and future potential. Over the past decade, Sanofi and Taro Pharmaceutical Industries Ltd. have showcased contrasting trends in their gross profit margins.
Sanofi, a global leader, has seen a steady increase in its gross profit, peaking in 2023 with a remarkable 46% growth from 2014. This upward trajectory highlights Sanofi's robust market strategies and successful product lines. In contrast, Taro's gross profit has experienced a decline, dropping by approximately 54% from its 2016 peak. This decline may reflect challenges in market competition or shifts in consumer demand.
As we look to the future, the missing data for 2024 leaves room for speculation. Will Taro rebound, or will Sanofi continue its dominance? Only time will tell.
Johnson & Johnson vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Sanofi vs Vertex Pharmaceuticals Incorporated: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Sanofi vs Bio-Techne Corporation
Gross Profit Trends Compared: Sanofi vs Halozyme Therapeutics, Inc.
Sanofi vs Corcept Therapeutics Incorporated: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Sanofi and HUTCHMED (China) Limited
Sanofi vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Sanofi vs Taro Pharmaceutical Industries Ltd.: Annual Revenue Growth Compared
Gross Profit Analysis: Comparing Sanofi and Amphastar Pharmaceuticals, Inc.
Gross Profit Trends Compared: Regeneron Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Gross Profit Analysis: Comparing Viatris Inc. and Taro Pharmaceutical Industries Ltd.
Pharming Group N.V. vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown